111 related articles for article (PubMed ID: 23866285)
1. [Preliminary study on the efficacy of irinotecan in the treatment of childhood relapsed hepatoblastoma].
Chang J; Zhang YT; Zhong XD; Wang LZ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):588-90. PubMed ID: 23866285
[No Abstract] [Full Text] [Related]
2. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer RD; Williams DM
Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
[No Abstract] [Full Text] [Related]
3. Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan.
Ijichi O; Ishikawa S; Shinkoda Y; Tanabe T; Okamoto Y; Takamatsu H; Inomata Y; Kawano Y
Pediatr Transplant; 2006 Aug; 10(5):635-8. PubMed ID: 16857004
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
Pediatr Blood Cancer; 2010 May; 54(5):761-3. PubMed ID: 20063426
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches in the treatment of children with hepatoblastoma.
Katzenstein HM; Rigsby C; Shaw PH; Mitchell TL; Haut PR; Kletzel M
J Pediatr Hematol Oncol; 2002 Dec; 24(9):751-5. PubMed ID: 12468918
[TBL] [Abstract][Full Text] [Related]
7. Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Natarajan E; Auerbach C; Cheron R; Pashankar F
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e659-e661. PubMed ID: 31259823
[TBL] [Abstract][Full Text] [Related]
8. [Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa T; Akaike A; Ushio J; Sato A; Matsukawa M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():203-6. PubMed ID: 16457250
[No Abstract] [Full Text] [Related]
9. Successful clinical response to irinotecan in relapsed neuroblastoma.
Shitara T; Shimada A; Tsuchida Y; Suzuki N; Toki F; Kuroiwa M
Med Pediatr Oncol; 2003 Feb; 40(2):126-8. PubMed ID: 12461801
[No Abstract] [Full Text] [Related]
10. Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
Vassal G; Couanet D; Stockdale E; Geoffray A; Geoerger B; Orbach D; Pichon F; Gentet JC; Picton S; Bergeron C; Cisar L; Assadourian S; Morland B; ;
J Clin Oncol; 2007 Feb; 25(4):356-61. PubMed ID: 17264330
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan as a maintenance therapy for hepatoblastoma: a comment.
Wiwanitkit V
J Cancer Res Ther; 2010; 6(4):588. PubMed ID: 21358112
[No Abstract] [Full Text] [Related]
12. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
Sato T; Hatate K; Ikeda A; Yamanashi T; Ozawa H; Onosato W; Nakamura T; Ihara A; Watanabe M
Expert Opin Pharmacother; 2008 May; 9(7):1223-8. PubMed ID: 18422478
[TBL] [Abstract][Full Text] [Related]
13. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
14. Vincristine and irinotecan in children with relapsed hepatoblastoma: a single-institution experience.
Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
Pediatr Hematol Oncol; 2015 Feb; 32(1):18-25. PubMed ID: 24852330
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab and irinotecan for recurrent oligodendroglial tumors.
Chamberlain MC
Neurology; 2010 Jan; 74(2):181. PubMed ID: 20065257
[No Abstract] [Full Text] [Related]
16. Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children's Oncology Group (COG) Phase I and II Studies.
Trobaugh-Lotrario AD; Meyers RL; Feusner JH
J Pediatr Hematol Oncol; 2016 Apr; 38(3):187-90. PubMed ID: 26583620
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.
Trobaugh-Lotrario AD; Katzenstein HM
Pediatr Blood Cancer; 2012 Nov; 59(5):809-12. PubMed ID: 22648979
[TBL] [Abstract][Full Text] [Related]
18. [Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan].
Adam R
Ann Chir; 2004 Mar; 129 Spec No 2():2-4. PubMed ID: 15255013
[No Abstract] [Full Text] [Related]
19. Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
Bomgaars LR; Bernstein M; Krailo M; Kadota R; Das S; Chen Z; Adamson PC; Blaney SM
J Clin Oncol; 2007 Oct; 25(29):4622-7. PubMed ID: 17925558
[TBL] [Abstract][Full Text] [Related]
20. Relapsed hepatoblastoma.
Trobaugh-Lotrario AD; Feusner JH
Pediatr Blood Cancer; 2012 Nov; 59(5):813-7. PubMed ID: 22648963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
